<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(10)</volume><submitter>Rogers KA</submitter><funding>NCI NIH HHS</funding><journal>Leukemia</journal><pagination>2527-2530</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7425823</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies.</pubmed_title><pmcid>PMC7425823</pmcid><funding_grant_id>P30 CA016058</funding_grant_id><funding_grant_id>K23 CA178183</funding_grant_id><funding_grant_id>R35 CA197734</funding_grant_id><funding_grant_id>R01 CA197870</funding_grant_id><pubmed_authors>Levine LB</pubmed_authors><pubmed_authors>Wiczer TE</pubmed_authors><pubmed_authors>Awan FT</pubmed_authors><pubmed_authors>Sullivan M</pubmed_authors><pubmed_authors>Bhat SA</pubmed_authors><pubmed_authors>Woyach JA</pubmed_authors><pubmed_authors>Guerrero T</pubmed_authors><pubmed_authors>Shindiapina P</pubmed_authors><pubmed_authors>Lucas F</pubmed_authors><pubmed_authors>Zhao Q</pubmed_authors><pubmed_authors>Sigmund AM</pubmed_authors><pubmed_authors>Byrd JC</pubmed_authors><pubmed_authors>El Boghdadly Z</pubmed_authors><pubmed_authors>Mousa L</pubmed_authors><pubmed_authors>Rogers KA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2025-04-22T02:59:59.233Z</modification><creation>2025-04-05T20:33:28.599Z</creation></dates><accession>S-EPMC7425823</accession><cross_references><pubmed>31086260</pubmed><doi>10.1038/s41375-019-0481-1</doi></cross_references></HashMap>